CHANGES IN GLUCOSE-TOLERANCE AND PLASMA-INSULIN DURING LIPID-LOWERING TREATMENT WITH DIET, CLOFIBRATE AND NICERITROL

被引：8

作者：

LITHELL, H ^{[1
]}

VESSBY, B ^{[1
]}

HELLSING, K ^{[1
]}

机构：

[1] UNIV UPPSALA,DEPT CLIN CHEM,S-75012 UPPSALA,SWEDEN

来源：

ATHEROSCLEROSIS | 1982年 / 43卷 / 2-3期

关键词：

D O I：

10.1016/0021-9150(82)90020-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：177 / 184

页数：8

共 17 条

[1]

BRUNS W, 1974, ENDOKRINOLOGIE, V64, P1

[2]

Carlson LA, 1971, METABOLIC EFFECTS NI, P157

[3] EFFECT OF CLOFIBRATE ON ARGININE-STIMULATED GLUCAGON AND INSULIN-SECRETION IN MAN [J].

EATON, RP ;

SCHADE, DS .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1974, 23 (05) :445-454

[4]

FELBER JP, 1971, METABOLIC EFFECTS NI, P695

[5]

GAUT ZN, 1971, METABOLIC EFFECTS NI, P923

[6] A METHODOLOGICAL STUDY OF ENZYMATIC DETERMINATION OF GLUCOSE IN BLOOD [J].

HJELM, M ;

VERDIER, CH .

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1963, 15 (04) :415-&

[7] NORMALIZATION OF LOW-DENSITY-LIPOPROTEIN LEVELS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH A COMBINED DRUG REGIMEN [J].

KANE, JP ;

MALLOY, MJ ;

TUN, P ;

PHILLIPS, NR ;

FREEDMAN, DD ;

WILLIAMS, ML ;

ROWE, JS ;

HAVEL, RJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (05) :251-258

[8] EFFECTS OF CLOFIBRATE ON GLUCOSE-TOLERANCE, SERUM-INSULIN, SERUM-LIPOPROTEINS AND PLASMA FIBRINOGEN [J].

LITHELL, H ;

BOBERG, J ;

HEDSTRAND, H ;

HELLSING, K ;

LJUNGHALL, S ;

VESSBY, B .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 12 (01) :51-57

[9] THE EFFECTS OF COLESTIPOL WHEN COMBINED WITH CLOFIBRATE IN THE TREATMENT OF SEVERE HYPERLIPIDEMIA - SHORT-TERM AND LONG-TERM STUDIES [J].

LITHELL, H ;

VESSBY, B ;

BOBERG, J ;

HELLSING, K .

ATHEROSCLEROSIS, 1980, 37 (02) :175-186

[10] CONTROLLED CLINICAL TRIAL OF A NEW BILE ACID SEQUESTERING RESIN, COLESTIPOL, IN TREATMENT OF HYPERCHOLESTEROLEMIA [J].

MILLER, NE ;

CLIFTONB.P ;

NESTEL, PJ ;

WHYTE, HM .

MEDICAL JOURNAL OF AUSTRALIA, 1973, 1 (25) :1223-1227

← 1 2 →